Search by Drug Name or NDC

NDC 61958-1003-02 Ranexa 500 mg/1 Details

Ranexa 500 mg/1

Ranexa is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is RANOLAZINE.

MedlinePlus Drug Summary

Ranolazine is used alone or with other medications to treat chronic angina (ongoing chest pain or pressure that is felt when the heart does not get enough oxygen). Ranolazine is in a class of medications called anti-anginals. The exact way that ranolazine works is not known at this time.

Related Packages: 61958-1003-02
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ranolazine

Product Information

NDC	61958-1003
Product ID	61958-1003_ba1f4469-5e3c-447a-9d28-8e57a2c32a17
Associated GPIs	32200040007420
GCN Sequence Number	060333
GCN Sequence Number Description	ranolazine TAB ER 12H 500 MG ORAL
HIC3	A2C
HIC3 Description	ANTIANGINAL, ANTI-ISCHEMIC AGENTS,NON-HEMODYNAMIC
GCN	26459
HICL Sequence Number	033446
HICL Sequence Number Description	RANOLAZINE
Brand/Generic	Brand
Proprietary Name	Ranexa
Proprietary Name Suffix	n/a
Non-Proprietary Name	RANOLAZINE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	500
Active Ingredient Units	mg/1
Substance Name	RANOLAZINE
Labeler Name	Gilead Sciences, Inc.
Pharmaceutical Class	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA021526
Listing Certified Through	2022-12-31

Package

NDC 61958-1003-02 (61958100302)

Pricing Information	N/A
NDC Package Code	61958-1003-2
Billing NDC	61958100302
Package	14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (61958-1003-2)
Marketing Start Date	2006-01-27
NDC Exclude Flag	N